Aliccia Bollig-Fischer
Aliccia Bollig-Fischer
Wayne State University, Barbara Ann Karmanos Cancer Institute
Verified email at
Cited by
Cited by
Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer
G Liu, A Bollig-Fischer, B Kreike, MJ van de Vijver, J Abrams, SP Ethier, ...
Oncogene 28 (50), 4491-4500, 2009
Overexpression of Cyclin D1 Promotes Tumor Cell Growth and Confers Resistance to Cisplatin-Mediated Apoptosis in an Elastase-myc Transgene–Expressing …
H Biliran Jr, Y Wang, S Banerjee, H Xu, H Heng, A Thakur, A Bollig, ...
Clinical Cancer Research 11 (16), 6075-6086, 2005
An estrogen receptor-α splicing variant mediates both positive and negative effects on gene transcription
A Bollig, RJ Miksicek
Molecular endocrinology 14 (5), 634-649, 2000
Genes associated with prostate cancer are differentially expressed in African American and European American men
IJ Powell, G Dyson, S Land, J Ruterbusch, CH Bock, S Lenk, M Herawi, ...
Cancer epidemiology, biomarkers & prevention 22 (5), 891-897, 2013
Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes
ST Guest, ZR Kratche, A Bollig-Fischer, R Haddad, SP Ethier
Experimental cell research 332 (2), 223-235, 2015
Aberrant Expression of X-Linked Genes RbAp46, Rsk4, and Cldn2 in Breast Cancer
A Thakur, KMW Rahman, J Wu, A Bollig, H Biliran, X Lin, H Nassar, ...
Molecular cancer research 5 (2), 171-181, 2007
Transforming properties of 8p11-12 amplified genes in human breast cancer
ZQ Yang, G Liu, A Bollig-Fischer, CN Giroux, SP Ethier
Cancer research 70 (21), 8487-8497, 2010
Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells
A Thakur, Y Sun, A Bollig, J Wu, H Biliran, S Banerjee, FH Sarkar, DJ Liao
Clinical cancer research 14 (14), 4427-4436, 2008
Expression profile of microRNAs in c-Myc induced mouse mammary tumors
Y Sun, J Wu, S Wu, A Thakur, A Bollig, Y Huang, D Joshua Liao
Breast cancer research and treatment 118, 185-196, 2009
Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4
A Ahmad, KR Ginnebaugh, S Yin, A Bollig-Fischer, KB Reddy, FH Sarkar
BMC cancer 15 (1), 1-10, 2015
Minireview: the molecular and genomic basis for prostate cancer health disparities
IJ Powell, A Bollig-Fischer
Molecular endocrinology 27 (6), 879-891, 2013
Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1
B Bao, AS Azmi, A Aboukameel, A Ahmad, A Bolling-Fischer, S Sethi, ...
Journal of Biological Chemistry 289 (21), 14520-14533, 2014
Intronic non-CG DNA hydroxymethylation and alternative mRNA splicing in honey bees
P Cingolani, X Cao, RS Khetani, CC Chen, M Coon, A Sammak, ...
BMC genomics 14, 1-15, 2013
Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity
B Bao, C Mitrea, P Wijesinghe, L Marchetti, E Girsch, RL Farr, JL Boerner, ...
Scientific reports 7 (1), 44125, 2017
C-Myc–induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-κB activity in pancreatic cancer cells
H Biliran Jr, S Banerjee, A Thakur, FH Sarkar, A Bollig, F Ahmed, J Wu, ...
Clinical cancer research 13 (9), 2811-2821, 2007
Racial disparities in the molecular landscape of cancer
EI Heath, F Lynce, J Xiu, A Ellerbrock, SK Reddy, E Obeid, SV Liu, ...
Anticancer Research 38 (4), 2235-2240, 2018
Racial diversity of actionable mutations in non–small cell lung cancer
A Bollig-Fischer, W Chen, SM Gadgeel, AS Wenzlaff, ML Cote, ...
Journal of Thoracic Oncology 10 (2), 250-255, 2015
The role of X-linked genes in breast cancer
A Thakur, H Xu, Y Wang, A Bollig, H Biliran, JD Liao
Breast cancer research and treatment 93, 135-143, 2005
Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice
A Thakur, A Bollig, J Wu, DJ Liao
Molecular cancer 7, 1-16, 2008
Methylation‐associated silencing of SFRP1 with an 8p11‐12 amplification inhibits canonical and non‐canonical WNT pathways in breast cancers
ZQ Yang, G Liu, A Bollig‐Fischer, R Haddad, AL Tarca, SP Ethier
International journal of cancer 125 (7), 1613-1621, 2009
The system can't perform the operation now. Try again later.
Articles 1–20